Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acellular Pertussis”

192 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 192 results

Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Early research (Phase 1)Ended earlyNCT04793620
What this trial is testing

Pertussis Acellular Vaccine Adjuvanted With TQL1055

Who this might be right for
Pertussis
Adjuvance Technologies, Inc. 72
Not applicableStudy completedNCT00297856
What this trial is testing

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 10,000
Early research (Phase 1)Looking for participantsNCT06184542
What this trial is testing

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Who this might be right for
DiphtheriaTetanusPertussis
Institute of Medical Biology, Chinese Academy of Medical Sciences 460
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Large-scale testing (Phase 3)Study completedNCT01642589
What this trial is testing

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 300
Early research (Phase 1)Study completedNCT02382913
What this trial is testing

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Who this might be right for
Pertussis
Novartis 315
Post-approval studies (Phase 4)Study completedNCT00514059
What this trial is testing

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Norwegian Institute of Public Health 83
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Large-scale testing (Phase 3)Study completedNCT00258908
What this trial is testing

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

Who this might be right for
DiphtheriaTetanusPertussis
Sanofi Pasteur, a Sanofi Company 115
Post-approval studies (Phase 4)Ended earlyNCT03188458
What this trial is testing

Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia

Who this might be right for
Diphtheria-Tetanus-Acellular Pertussis
GlaxoSmithKline 18
Not applicableUnknownNCT02765126
What this trial is testing

Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly

Who this might be right for
Heterologous Effects of Vaccines
Clifford Craig Medical Research Trust 450
Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline
Large-scale testing (Phase 3)Study completedNCT00518180
What this trial is testing

Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

Who this might be right for
Meningococcal MeningitisHuman Papillomavirus InfectionPertussis+1 more
Novartis Vaccines 1,620
Large-scale testing (Phase 3)Study completedNCT00879827
What this trial is testing

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

Who this might be right for
DiphtheriaPoliomyelitisHepatitis B+2 more
GlaxoSmithKline 60
Large-scale testing (Phase 3)Study completedNCT02458183
What this trial is testing

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Boryung Pharmaceutical Co., Ltd 476
Large-scale testing (Phase 3)Study completedNCT00379977
What this trial is testing

Study to Assess the Safety & Reactogenicity of GSK Biologicals' DTPa/Hib Vaccine When Given at 3, 4 and 5 Months of Age

Who this might be right for
TetanusHaemophilus Influenzae Type bAcellular Pertussis+1 more
GlaxoSmithKline 30
Testing effectiveness (Phase 2)Study completedNCT00970307
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age

Who this might be right for
TetanusDiphtheriaHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 421
Large-scale testing (Phase 3)Study completedNCT00287092
What this trial is testing

Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Sanofi Pasteur, a Sanofi Company 807
Next Page